Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
35.53
+1.80 (5.34%)
Feb 21, 2025, 4:00 PM EST - Market closed
Moderna Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
Cash & Equivalents | 1,927 | 2,907 | 3,205 | 6,848 | 2,624 | Upgrade
|
Short-Term Investments | 5,098 | 5,697 | 6,697 | 3,879 | 1,984 | Upgrade
|
Cash & Short-Term Investments | 7,025 | 8,604 | 9,902 | 10,727 | 4,608 | Upgrade
|
Cash Growth | -18.35% | -13.11% | -7.69% | 132.79% | 317.77% | Upgrade
|
Accounts Receivable | 358 | 892 | 1,385 | 3,175 | 1,391 | Upgrade
|
Other Receivables | - | 189 | 264 | 148 | 17 | Upgrade
|
Receivables | 358 | 1,081 | 1,685 | 3,323 | 1,408 | Upgrade
|
Inventory | 117 | 270 | 1,168 | 1,728 | 47 | Upgrade
|
Prepaid Expenses | 599 | 266 | 254 | 126 | 7 | Upgrade
|
Restricted Cash | - | - | - | - | 1 | Upgrade
|
Other Current Assets | - | 104 | 422 | 167 | 227 | Upgrade
|
Total Current Assets | 8,099 | 10,325 | 13,431 | 16,071 | 6,298 | Upgrade
|
Property, Plant & Equipment | 2,955 | 2,658 | 2,139 | 1,383 | 387 | Upgrade
|
Long-Term Investments | 2,494 | 4,743 | 8,360 | 6,843 | 639 | Upgrade
|
Goodwill | - | 52 | - | - | - | Upgrade
|
Other Intangible Assets | - | 44 | - | - | - | Upgrade
|
Long-Term Deferred Tax Assets | - | 81 | 982 | 326 | - | Upgrade
|
Other Long-Term Assets | 594 | 523 | 946 | 46 | 13 | Upgrade
|
Total Assets | 14,142 | 18,426 | 25,858 | 24,669 | 7,337 | Upgrade
|
Accounts Payable | 405 | 520 | 487 | 302 | 18 | Upgrade
|
Accrued Expenses | 1,427 | 1,069 | 1,828 | 1,472 | 470 | Upgrade
|
Current Portion of Leases | - | 25 | 196 | 211 | 30 | Upgrade
|
Current Income Taxes Payable | - | 63 | 48 | 876 | - | Upgrade
|
Current Unearned Revenue | 153 | 568 | 2,038 | 6,253 | 3,867 | Upgrade
|
Other Current Liabilities | 221 | 770 | 326 | 14 | 4 | Upgrade
|
Total Current Liabilities | 2,206 | 3,015 | 4,923 | 9,128 | 4,389 | Upgrade
|
Long-Term Leases | 710 | 1,218 | 1,004 | 705 | 207 | Upgrade
|
Long-Term Unearned Revenue | 58 | 83 | 673 | 615 | 177 | Upgrade
|
Other Long-Term Liabilities | 267 | 256 | 135 | 76 | 3 | Upgrade
|
Total Liabilities | 3,241 | 4,572 | 6,735 | 10,524 | 4,776 | Upgrade
|
Additional Paid-In Capital | 866 | 371 | 1,173 | 4,211 | 4,802 | Upgrade
|
Retained Earnings | 10,045 | 13,606 | 18,320 | 9,958 | -2,244 | Upgrade
|
Comprehensive Income & Other | -10 | -123 | -370 | -24 | 3 | Upgrade
|
Total Common Equity | 10,901 | 13,854 | 19,123 | 14,145 | 2,561 | Upgrade
|
Shareholders' Equity | 10,901 | 13,854 | 19,123 | 14,145 | 2,561 | Upgrade
|
Total Liabilities & Equity | 14,142 | 18,426 | 25,858 | 24,669 | 7,337 | Upgrade
|
Total Debt | 710 | 1,243 | 1,200 | 916 | 237 | Upgrade
|
Net Cash (Debt) | 8,809 | 12,038 | 17,020 | 16,654 | 5,010 | Upgrade
|
Net Cash Growth | -26.82% | -29.27% | 2.20% | 232.42% | 418.07% | Upgrade
|
Net Cash Per Share | 22.94 | 31.51 | 40.91 | 38.64 | 13.15 | Upgrade
|
Filing Date Shares Outstanding | 385 | 382.07 | 386.34 | 402.87 | 399.77 | Upgrade
|
Total Common Shares Outstanding | 385 | 382 | 385 | 403 | 398.79 | Upgrade
|
Working Capital | 5,893 | 7,310 | 8,508 | 6,943 | 1,909 | Upgrade
|
Book Value Per Share | 28.31 | 36.27 | 49.67 | 35.10 | 6.42 | Upgrade
|
Tangible Book Value | 10,901 | 13,758 | 19,123 | 14,145 | 2,561 | Upgrade
|
Tangible Book Value Per Share | 28.31 | 36.02 | 49.67 | 35.10 | 6.42 | Upgrade
|
Land | - | 22 | 11 | - | - | Upgrade
|
Machinery | - | 445 | 343 | 211 | 139 | Upgrade
|
Construction In Progress | - | 860 | 281 | 212 | 35 | Upgrade
|
Leasehold Improvements | - | 522 | 460 | 313 | 180 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.